BiochemistrybioRxivPreprint
KPB82 potently and selectively inhibits ACER2 and protects tumor and primary cells from doxorubicin-induced cytotoxicity
Arpita Devi, Ruijuan Xu, Szulc Zdzislaw…·Cungui Mao
This paper identifies KPB82 as a potent and selective ACER2 inhibitor that reduces doxorubicin-induced cytotoxicity in multiple cell types.
DOI 10.64898/2026.09.29.754712